HALO vs NIVF (Halozyme Therapeutics Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Oct 5 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Today's Session Official Close
The regular trading session has completed and official closing prices are verified as of 6:05 PM ET. All metrics below represent finalized session performance.
HALO leads by +11.57% Alpha Spread Today
HALO is trading at +1.30% while NIVF is at -10.27% .
Started At
Official opening auction price
Closed At
Official exchange closing price
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | HALO | NIVF | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | +1.30% | -10.27% | HALO +11.57% |
| Net Dollar Move | +$1.41 | $-0.01 | HALO higher move |
| Open Price | $108.87 | $0.10 | Gap: 0.52% vs -9.09% |
| Day High | $111.25 | $0.11 | Session peaks |
| Day Low | $107.43 | $0.09 | Session troughs |
| Intraday Spread | $3.82 | $0.02 | High/Low spread |
| Share Volume | 1.77M | 11.70M | NIVF more active |
| Est. Dollar Volume | $194.09M | $1.17M | HALO higher liquidity |
Explore HALO vs NIVF Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.